Bard Associates Inc Harrow Health, Inc. Call Options Transaction History
Bard Associates Inc
- $266 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.4MCall Options Held
381KPut Options Held
443K-
Opaleye Management Inc. Boston, MA3.91MShares$136 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$74.8 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$67.8 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$65.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$30.4 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $943M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...